Intended for healthcare professionals
Our CompanySubscribeMy AccountLogin

Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca vaccine

Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca vaccine

New study shows slightly increased rates of vein blood clots, however, the risk of such adverse events is considered low

EditorialThromboembolism and the Oxford-AstraZeneca vaccineOpinionThrombosis and bleeding after the Oxford-AstraZeneca covid-19 vaccination
AZ vaccine
AZ vaccine
critical care
Where are we with drug treatments for covid-19?

A year since the pandemic began, just a handful of drugs have been approved as covid-19 treatments. What are the ongoing major trials?

feature  |  May 7
Where are we with drug treatments for covid-19?

A year since the pandemic began, just a handful of drugs have been approved as covid-19 treatments. What are the ongoing major trials?

critical care
feature

May 7

Latest articles

News

News channel image

Covid-19 vaccines

UK Jobs

St George's University Hospitals NHS Foundation Trust: Consultant in Clinical Genetics

Current issue

latest issue

Most read

1.

Community

Latest responses

View more

What are your thoughts?

Total altmetrics

Altmetric Badge